България - Фармацевтични продукти - „Доставка на противотуморни лекарствени продукти за нуждите на СБАЛО „Свети Мина“ ЕООД, гр. Благоевград - първа част“ по обособени позиции

different companies won its awards

21

of the awards went to the three most frequent winners

45%

of its calls state an estimated value

100%

Based on 66 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

1.7

of those lots received a single tender

46%

of the awards went to companies based in another country

0%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Bulgaria · Medical equipment & pharmaceuticals

different companies won awards here

1,076

of the awards went to the three most frequent winners

16%

buyers awarded contracts here

188

Based on 4,245 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)

2.8

of those lots received a single tender

38%

of the awards went to companies based in another country

1%

of the tenders came from another country

1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.